Title: Sugars & proteins: towards a synthetic biology
Our work studies the interplay of biomolecules – proteins, sugars and their modifications.
Synthetic Biology’s development at the start of this century may be compared with Synthetic Organic Chemistry’s expansion at the start of the last; after decades of isolation, identification, analysis and functional confirmation, the future logical and free-ranging redesign of biomacromolecules offers tantalizing opportunities.
This lecture will cover past and emerging areas in our group in the chemical manipulation of biomolecules with an emphasis on new bond-forming and bond-breaking processes compatible with biology:
(i) New methods: the development of precise methods that may be applied to biology at a post-translational level, generating minimal ‘scars’ or ‘traces’ (ideally ‘trace’-less), could allow broad control of function. The development of chemo- and regio-selective methods with potential to post-translationally ‘edit’ biology in this way, applied under benign conditions to redesign and reprogramme the structure and function of biomolecules, will be presented.
(ii) ‘Synthetic Biologics’ and their applications: biomimicry; functional recapitulation; effector [drug/agrochemical/gene/radio-dose] delivery; selective protein degradation; inhibitors of pathogen interactions; non-invasive presymptopmatic disease diagnosis; probes and modulators of in vitro and in vivo function illustrate possible resulting technologies.
LOCATION:Pfizer Lecture Hall STATUS:CONFIRMED DTSTART:20231005T201500Z DTEND:20231005T211500Z END:VEVENT END:VCALENDAR